Yilong Zhang Selected Research

Yilong Zhang Research Topics

Disease

12	Neoplasms (Cancer) 12/2021 - 11/2006
4	Stomach Neoplasms (Stomach Cancer) 11/2017 - 01/2014
3	Melanoma (Melanoma, Malignant) 10/2022 - 01/2016
3	Malaria 06/2022 - 11/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2021
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 03/2018
3	Neutropenia 11/2017 - 03/2011
2	Obesity 01/2022 - 01/2019
2	Overweight 01/2022 - 01/2022
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2021
2	Disease Progression 11/2017 - 01/2016
2	Arthritis (Polyarthritis) 01/2017 - 03/2008
2	monomelic Amyotrophy 02/2016 - 10/2015
2	Infections 03/2011 - 01/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2023
1	Osteoarthritis 04/2023
1	Pain (Aches) 04/2023
1	Pathologic Processes 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Bites and Stings (Sting) 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Inflammation (Inflammations) 12/2021
1	Central Nervous System Diseases (CNS Diseases) 06/2021
1	Seizures (Absence Seizure) 05/2021
1	Epilepsy (Aura) 05/2021
1	Cognitive Dysfunction 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Facies 02/2018
1	Thrombocytopenia (Thrombopenia) 11/2017
1	Fatigue 11/2017
1	Adenocarcinoma 11/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2017
1	Compression Fractures (Compression Fracture) 10/2017
1	Rheumatoid Arthritis 01/2017
1	Experimental Arthritis 01/2017

Drug/Important Bio-Agent (IBA)

6	rilotumumabIBA 11/2017 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2016
5	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 06/2015
4	Capecitabine (Xeloda)FDA Link 11/2017 - 06/2015
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 01/2019
3	LigandsIBA 06/2021 - 11/2017
3	Epirubicin (Ellence)FDA LinkGeneric 11/2017 - 06/2015
2	AutoantibodiesIBA 01/2022 - 01/2022
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2019
2	hesperetinIBA 06/2021 - 01/2021
2	Paliperidone Palmitate FDA Link 01/2021 - 01/2021
2	Monoclonal AntibodiesIBA 01/2017 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 11/2006
2	pasireotideIBA 10/2012 - 07/2012
2	SulfurIBA 11/2008 - 11/2006
2	(((4- nitrophenyl)amino)(2,2,4,4- tetramethyl thiochroman-6-yl)amino) methane-1-thioneIBA 11/2008 - 11/2006
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 11/2008 - 11/2006
1	Oxygen (Dioxygen)IBA 09/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023
1	Circular RNAIBA 01/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2022
1	InsecticidesIBA 06/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	aluminum sulfate (alum)IBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Interleukin-11 (Interleukin 11)IBA 12/2021
1	CateninsIBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	130-nm albumin-bound paclitaxelIBA 12/2021
1	GasotransmittersIBA 05/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2021
1	Protein Kinase CIBA 05/2021
1	carbazoleIBA 05/2021
1	Aquaporin 4IBA 05/2021
1	Pentylenetetrazole (Metrazol)IBA 05/2021
1	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 05/2021
1	Trace Elements (Biometals)IBA 01/2021
1	IonsIBA 01/2021
1	Scopolamine (Hyoscine)FDA Link 01/2021
1	Particulate MatterIBA 01/2020
1	Insulin Glargine (Lantus)FDA Link 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2018
1	ClayIBA 02/2018
1	SandIBA 02/2018
1	Carboplatin (JM8)FDA LinkGeneric 11/2017
1	Etoposide (VP 16)FDA LinkGeneric 11/2017
1	ganitumabIBA 11/2017
1	PlatinumIBA 11/2017
1	flavanoneIBA 01/2017
1	GlycosidesIBA 01/2017
1	HesperidinIBA 01/2017
1	AntioxidantsIBA 01/2017
1	WD repeat containing planar cell polarity effectorIBA 01/2017

Therapy/Procedure

11	Therapeutics 09/2023 - 10/2012
2	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 11/2017 - 11/2017
1	Activities of Daily Living (ADL) 09/2023
1	Acupressure (Shiatsu) 04/2023
1	Glycemic Control 01/2022